ARTICLE | Clinical News
Isis Pharmaceuticals preclinical data
July 6, 2009 7:00 AM UTC
In diet-induced mice, Isis said antisense reduction of retinol binding protein 4 plasma (RBP4) produced significant improvements in insulin sensitivity and cardiac glucose metabolism. The company sai...